AVYCAZ Drug Patent Profile
✉ Email this page to a colleague
When do Avycaz patents expire, and what generic alternatives are available?
Avycaz is a drug marketed by Abbvie and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has one hundred and ninety-five patent family members in fifty-five countries.
The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.
DrugPatentWatch® Generic Entry Outlook for Avycaz
Avycaz was eligible for patent challenges on February 25, 2019.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be June 15, 2032. This may change due to patent challenges or generic licensing.
There is one Paragraph IV patent challenge for this drug. This may lead to patent invalidation or a license for generic production.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AVYCAZ?
- What are the global sales for AVYCAZ?
- What is Average Wholesale Price for AVYCAZ?
Summary for AVYCAZ
International Patents: | 195 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 3 |
Drug Prices: | Drug price information for AVYCAZ |
What excipients (inactive ingredients) are in AVYCAZ? | AVYCAZ excipients list |
DailyMed Link: | AVYCAZ at DailyMed |


DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for AVYCAZ
Generic Entry Date for AVYCAZ*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
POWDER;IV (INFUSION) |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for AVYCAZ
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
Michigan State University | Phase 1 |
University of Southern California | Phase 4 |
Pharmacology for AVYCAZ
Drug Class | Cephalosporin Antibacterial beta Lactamase Inhibitor |
Mechanism of Action | beta Lactamase Inhibitors |
Paragraph IV (Patent) Challenges for AVYCAZ
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AVYCAZ | For Injection | avibactam sodium; ceftazidime | 0.5 g/2 g per vial | 206494 | 2 | 2024-02-26 |
US Patents and Regulatory Information for AVYCAZ
AVYCAZ is protected by ten US patents and four FDA Regulatory Exclusivities.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of AVYCAZ is ⤷ Try for Free.
This potential generic entry date is based on patent 8,969,566.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | AVYCAZ | avibactam sodium; ceftazidime | POWDER;INTRAVENOUS | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | 7,112,592 | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
Abbvie | AVYCAZ | avibactam sodium; ceftazidime | POWDER;INTRAVENOUS | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | 8,471,025 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Abbvie | AVYCAZ | avibactam sodium; ceftazidime | POWDER;INTRAVENOUS | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AVYCAZ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | AVYCAZ | avibactam sodium; ceftazidime | POWDER;INTRAVENOUS | 206494-001 | Feb 25, 2015 | 8,178,554 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AVYCAZ
When does loss-of-exclusivity occur for AVYCAZ?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 6972
Patent: PROCESOS PARA PREPARAR COMPUESTOS HETEROCICLICOS, QUE INCLUYEN TRANS-7-OXO-6-(SULFOOXI)-1,6-DIAZABICICLO[3,2,1]OCTANO-2-CARBOXAMIDA Y SALES DE LA MISMA
Estimated Expiration: ⤷ Try for Free
Australia
Patent: 12270051
Patent: Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Estimated Expiration: ⤷ Try for Free
Brazil
Patent: 2013032415
Estimated Expiration: ⤷ Try for Free
Canada
Patent: 80403
Patent: PROCEDES DE PREPARATION DE COMPOSES HETEROCYCLIQUES, Y COMPRIS LE TRANS-7-OXO-6-(SULFOXY)-1,6-DIAZABICYCLO¬3,2,1|OCTANE-2-CARBOXAMIDE ET SES SELS (PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF)
Estimated Expiration: ⤷ Try for Free
China
Patent: 3649051
Patent: Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1, 6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Estimated Expiration: ⤷ Try for Free
Patent: 5294690
Patent: PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF
Estimated Expiration: ⤷ Try for Free
European Patent Office
Patent: 21005
Patent: PROCÉDÉ DE PRÉPARATION DE COMPOSÉS HÉTÉROCYCLIQUES, NOTAMMENT LE TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE ET SES SELS (PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF)
Estimated Expiration: ⤷ Try for Free
Hong Kong
Patent: 96615
Patent: 製備包括反式- -氧- 磺酰氧基 -二氮二環 辛烷- -氨甲酰及其鹽的雜環化合物的方法 (PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6- (SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF -7--6-()-16-[321]-2-)
Estimated Expiration: ⤷ Try for Free
Israel
Patent: 9815
Patent: תהליך להכנת הטרוציקליות הכוללות טרנס- 7 - אוקסו - 6 - (סולפואוקסי) - 1, 6 - דיאזאביציקלו [1,2,3] אוקטאן - 2 - קרבוקסאמיד ומלחים שלהן (Process for preparing heterocyclic compounds including trans-7-oxo- 6 -(sulphooxy)-1, 6 - diazabicyclo [3,2,1] octane- 2-carboxamide and salts thereof)
Estimated Expiration: ⤷ Try for Free
Japan
Patent: 23800
Estimated Expiration: ⤷ Try for Free
Patent: 42462
Estimated Expiration: ⤷ Try for Free
Patent: 14517027
Estimated Expiration: ⤷ Try for Free
Patent: 17036307
Patent: trans−7−オキソ−6−(スルホオキシ)−1,6−ジアザビシクロ[3,2,1]オクタン−2−カルボキサミドとその塩が含まれる複素環式化合物を製造するための方法 (PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULFOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF)
Estimated Expiration: ⤷ Try for Free
Malaysia
Patent: 5730
Patent: PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF
Estimated Expiration: ⤷ Try for Free
Mexico
Patent: 1020
Patent: PROCESOS PARA PREPARAR COMPUESTOS HETEROCICLICOS, INCLUIDA TRANS-7-OXO-6-(SULFOOXI)-1,6-DIAZABICICLO [3,2,1]OCTANO-2-CARBOXAM IDA Y SALES DE LA MISMA. (PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBO XAMIDE AND SALTS THEREOF.)
Estimated Expiration: ⤷ Try for Free
Patent: 13014114
Patent: PROCESOS PARA PREPARAR COMPUESTOS HETEROCICLICOS, INCLUIDA TRANS-7-OXO-6-(SULFOOXI)-1,6-DIABAZABICICLO [3,2,1]OCTANO-2-CARBOX AMIDA Y SALES DE LA MISMA. (PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBO XAMIDE AND SALTS THEREOF.)
Estimated Expiration: ⤷ Try for Free
Russian Federation
Patent: 10091
Estimated Expiration: ⤷ Try for Free
Patent: 69076
Patent: СПОСОБ ПОЛУЧЕНИЯ ГЕТЕРОЦИКЛИЧЕСКИХ СОЕДИНЕНИЙ, ВКЛЮЧАЯ ТРАНС-7-ОКСО-6-(СУЛЬФОКСИ)-1,6-ДИАЗАБИЦИКЛО[3.2.1]ОКТАН-2-КАРБОКСАМИД И ЕГО СОЛИ (METHOD OF PRODUCING HETEROCYCLIC COMPOUNDS, INCLUDING TRANS-7-OXO-6-(SULPHOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE AND ITS SALT)
Estimated Expiration: ⤷ Try for Free
Patent: 14101244
Patent: СПОСОБ ПОЛУЧЕНИЯ ГЕТЕРОЦИКЛИЧЕСКИХ СОЕДИНЕНИЙ, ВКЛЮЧАЯ ТРАНС-7-ОКСО-6-(СУЛЬФООКСИ)-1, 6-ДИАЗАБИЦИКЛО[3,2,1]ОКТАН-2-КАРБОКСАМИД И ЕГО СОЛИ
Estimated Expiration: ⤷ Try for Free
Patent: 17102358
Patent: СПОСОБ ПОЛУЧЕНИЯ ГЕТЕРОЦИКЛИЧЕСКИХ СОЕДИНЕНИЙ, ВКЛЮЧАЯ ТРАНС-7-ОКСО-6-(СУЛЬФООКСИ)-1,6-ДИАЗАБИцикло[3,2,1]ОКТАН-2-КАРБОКСАМИД И ЕГО СОЛИ
Estimated Expiration: ⤷ Try for Free
Singapore
Patent: 5289
Patent: PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF
Estimated Expiration: ⤷ Try for Free
South Korea
Patent: 2143660
Estimated Expiration: ⤷ Try for Free
Patent: 140040748
Patent: PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF
Estimated Expiration: ⤷ Try for Free
Spain
Patent: 60404
Estimated Expiration: ⤷ Try for Free
Taiwan
Patent: 65706
Estimated Expiration: ⤷ Try for Free
Patent: 1317238
Patent: Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1-,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Estimated Expiration: ⤷ Try for Free
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering AVYCAZ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | PA03000881 | NUEVOS COMPUESTOS HETEROCICLICOS, SU PREPARACION Y SU UTILIZACION COMO MEDICAMENTOS, EN ESPECIAL COMO ANTIBACTERIANOS. (AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE AS MEDICINES, IN PARTICULAR AS ANTIBACTERIAL AGENTS.) | ⤷ Try for Free |
Portugal | 2279737 | ⤷ Try for Free | |
Tunisia | SN04137 | NOUVEAUX COMPOSES HETEROCYCLIQUES, ACTIFS COMME INHIBITEURS DE BETA-LACTAMASES | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AVYCAZ
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1480644 | 122016000105 | Germany | ⤷ Try for Free | PRODUCT NAME: CEFTAZIDIM ODER EIN SALZ DAVON MIT AVIBACTAM ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/16/1109 20160624 |
1480644 | 132016000125850 | Italy | ⤷ Try for Free | PRODUCT NAME: MISCELA O ASSOCIAZIONE FARMACEUTICA CHE COMPRENDE COME PRINCIPI ATTIVI: (1) CEFTAZIDIMA O UN SUO SALE, E (2) AVIBACTAM O UN SUO SALE(ZAVICEFTA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/16/1109, 20160628 |
1480644 | C01480644/01 | Switzerland | ⤷ Try for Free | PRODUCT NAME: AVIBACTAM + CEFTAZIDIM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66890 05.06.2019 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory of Avycaz
More… ↓